[HTML][HTML] Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment
E Al Kahtani, Z Xu, S Al Rashaed, L Wu, A Mahale… - Eye, 2017 - nature.com
Eye, 2017•nature.com
Purpose Placental growth factor (PlGF) is a member of the VEGF family that plays an
important role in experimental models of diabetic retinopathy and retinal neovascularization.
We aimed to investigate whether vitreous levels of PlGF correlated with proliferative diabetic
retinopathy (PDR) status, VEGF levels, and bevacizumab treatment. We also analysed PDR
membranes to confirm the presence of the PlGF receptor, FLT1, in endothelial cells.
Methods This was a case-control study: undiluted vitreous fluid samples were obtained from …
important role in experimental models of diabetic retinopathy and retinal neovascularization.
We aimed to investigate whether vitreous levels of PlGF correlated with proliferative diabetic
retinopathy (PDR) status, VEGF levels, and bevacizumab treatment. We also analysed PDR
membranes to confirm the presence of the PlGF receptor, FLT1, in endothelial cells.
Methods This was a case-control study: undiluted vitreous fluid samples were obtained from …
Abstract
Purpose
Placental growth factor (PlGF) is a member of the VEGF family that plays an important role in experimental models of diabetic retinopathy and retinal neovascularization. We aimed to investigate whether vitreous levels of PlGF correlated with proliferative diabetic retinopathy (PDR) status, VEGF levels, and bevacizumab treatment. We also analysed PDR membranes to confirm the presence of the PlGF receptor, FLT1, in endothelial cells.
Methods
This was a case-control study: undiluted vitreous fluid samples were obtained from 28 active PDR patients without preoperative bevacizumab treatment, 21 active PDR patients with preoperative bevacizumab treatment, 18 inactive PDR patients, and 21 control patients. PlGF and VEGF levels in samples were determined by enzyme-linked immunosorbent assay. Immunohistochemistry for FLT1 was performed on human PDR membranes.
Results
Compared to control, vitreous PlGF levels were higher in both active PDR without bevacizumab (P< 0.0001) and with bevacizumab (P< 0.0001). There was no significant difference in PlGF between active PDR patients without and with bevacizumab (P= 0.56). Compared to active PDR, PlGF levels were significantly reduced in inactive PDR (P= 0.004). PlGF levels were highly correlated with VEGF levels in active PDR. VEGFR1 was expressed in endothelial cells in human PDR membranes.
Conclusion
The strong correlation of PlGF levels with PDR disease status and expression of FLT1 in human PDR membranes suggest that PlGF has a pathogenic role in proliferative diabetic retinopathy. Therapeutic targeting of PlGF with agents like aflibercept may be beneficial.
nature.com
